as 05-20-2024 11:32am EST
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Founded: | 1987 | Country: | United States |
Employees: | N/A | City: | SAN DIEGO |
Market Cap: | 1.6B | IPO Year: | 1992 |
Target Price: | $116.33 | AVG Volume (30 days): | 188.3K |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 5.32 | EPS Growth: | 325.60 |
52 Week Low/High: | $49.24 - $94.57 | Next Earning Date: | 05-07-2024 |
Revenue: | $118,313,000 | Revenue Growth: | -41.92% |
Revenue Growth (this year): | 6.94% | Revenue Growth (next year): | 16.74% |
LGND Breaking Stock News: Dive into LGND Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Zacks
3 days ago
Zacks
3 days ago
Zacks
4 days ago
Zacks
4 days ago
GuruFocus.com
4 days ago
Zacks
5 days ago
Zacks
6 days ago